Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion type Assertion NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_head.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion description "[These findings suggest that delivery of microRNA-125a mimics or treatments that modulate its cellular expression may be valuable tools for the development of new therapeutic strategies for human diseases, including cancer and viral hepatitis B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_provenance.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion evidence source_evidence_literature NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_provenance.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion SIO_000772 23783428 NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_provenance.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion wasDerivedFrom befree-2016 NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_provenance.
- NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_assertion wasGeneratedBy ECO_0000203 NP1087383.RAXrxy-NHs_0K6avTP-oeLCelUI8qM9K68t1AAM8pKIB8130_provenance.